ClinConnect ClinConnect Logo
Search / Trial NCT03839992

Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis

Launched by GELB, ARTHUR F., M.D. · Feb 11, 2019

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Abnormal Fef75 Bronchiectasis Lung Ct

ClinConnect Summary

This clinical trial is looking to find out if there are small airway problems in children and adults with cystic fibrosis that are not usually detected during standard breathing tests. Even if these tests show normal results, the study aims to identify issues that could affect lung function. This research will help doctors understand cystic fibrosis better and improve care for patients.

To participate, you need to be a child or adult with cystic fibrosis who has normal results on routine breathing tests, which include measurements like FEV1, FVC, and the ratio of these two (FEV1/FVC%). Unfortunately, if you have any abnormal results on these tests, you won't be eligible for the study. If you join, you’ll help researchers learn more about cystic fibrosis and potentially improve treatment options for others in the future. The study is currently recruiting participants of all genders, ages ranging from 18 to 26 years old and 14 to 609 years old.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Heterozygote or homozygote patients with cystic fibrosis with normal routine pre bronchodilator spirometry including normal FEV1(L), FVC(L) and FEV1/FVC%.
  • Exclusion Criteria:Heterozygote or homozygote patients with cystic fibrosis with ABNORMAL routine pre bronchodilator spirometry
  • -

About Gelb, Arthur F., M.D.

Dr. Arthur F. Gelb, M.D., is a distinguished clinical trial sponsor with extensive experience in advancing medical research and improving patient outcomes. With a strong background in clinical medicine and a commitment to innovation, Dr. Gelb leads trials that focus on developing new therapies and interventions across various therapeutic areas. His dedication to rigorous scientific methodology and ethical standards ensures that all studies conducted under his sponsorship are designed to deliver reliable and impactful results. Dr. Gelb's leadership fosters collaboration among multidisciplinary teams, enhancing the potential for breakthroughs that can significantly benefit patient care and treatment options.

Locations

Lakewood, California, United States

Long Beach, California, United States

Patients applied

0 patients applied

Trial Officials

Arthur Gelb, MD

Principal Investigator

University of California, Los Angeles

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials